Archived research. Equity forecasting is part of the Runchey Research archive (methodology era 1) and is no longer actively updated. Everything remains published at its original URL. Browse the archive

Back to Forecasting

HIMS Forecast Markets

Hims & Hers Health, Inc.

7
Active Markets
3
Resolved
39%
Avg Probability

All Markets

10 markets

Will the DOJ file criminal charges against HIMS or any HIMS officer by September 30, 2026?

Active
19%
Likely No
21%19%after Q4 2025 earnings
94% agreement
Oct 15, 2026
IG: 0.80

Will HIMS report negative free cash flow (operating cash flow minus CapEx) for Q1 2026?

Active
38%
Likely No
91% agreement
Jun 15, 2026
IG: 0.79

Will HIMS Q1 2026 revenue fall below the guided floor of $600M?

Active
15%
Likely No
94% agreement
Jun 15, 2026
IG: 0.63

Will HIMS complete the Eucalyptus Health acquisition by September 30, 2026?

Active
76%
Likely Yes
86% agreement
Oct 15, 2026
IG: 0.63

Will the FDA publish final rules or take formal enforcement action restricting 503A compounding of semaglutide by June 30, 2026?

Active
60%
Likely Yes
65%60%after Q4 2025 earnings
89% agreement
Jul 15, 2026
IG: 0.60

Will a court grant Novo Nordisk a preliminary injunction against HIMS compounded semaglutide products by September 30, 2026?

Active
10%
Likely No
18%10%after Q4 2025 earnings
95% agreement
Oct 15, 2026
IG: 0.60

Will any HIMS insider make an open-market stock purchase by June 30, 2026?

Active
10%
Likely No
18%10%after Q4 2025 earnings
95% agreement
Jul 15, 2026
IG: 0.48

Will HIMS report Q4 2025 weight loss specialty revenue below $175M?

Resolved
68%
Likely Yes
Actual: YES
Brier: 0.102
Mar 17, 2026
IG: 0.80

Will HIMS report Q4 2025 year-over-year subscriber growth below 15%?

Resolved
65%
Likely Yes
Actual: YES
Brier: 0.123
Feb 23, 2026
IG: 0.64

Will HIMS management withdraw or materially reduce its $6.5B 2030 revenue target at Q4 2025 earnings?

Resolved
28%
Likely No
Actual: NO
Brier: 0.078
Feb 23, 2026
IG: 0.48